FDA Inspection 817237 — OneBlood, Inc.

OneBlood, Inc. — FEI 1070206

The FDA completed an inspection of OneBlood, Inc. on January 30, 2013 in Ocala, FL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
January 30, 2013
Fiscal Year
2013
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Ocala, FL (United States)